======= CRLF3 =======
== Gene Information ==
* **Official Symbol**: CRLF3
* **Official Name**: cytokine receptor like factor 3
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51379|51379]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q8IUI8|Q8IUI8]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=CRLF3&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CRLF3|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/614853|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a cytokine receptor-like factor that may negatively regulate cell cycle progression at the G0/G1 phase. Studies of the related rat protein suggest that it may regulate neuronal morphology and synaptic vesicle biogenesis. This gene is one of several genes located in the neurofibromatosis type I tumor suppressor region on the q arm of chromosome 17, a region that is subject to microdeletions, duplications, chromosomal breaks and rearrangements. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2 and 5. [provided by RefSeq, Aug 2012].
* **UniProt Summary**: May play a role in the negative regulation of cell cycle progression. {ECO:0000269|PubMed:19427400}.
No Pfam Domain information is available for this gene.
|positive regulation of cell cycle arrest|
|positive regulation of receptor signaling pathway via JAK-STAT|
|positive regulation of receptor signaling pathway via STAT|
|regulation of cell cycle arrest|
|G1/S transition of mitotic cell cycle|
|cell cycle G1/S phase transition|
|regulation of receptor signaling pathway via JAK-STAT|
|regulation of receptor signaling pathway via STAT|
|negative regulation of cell growth|
|negative regulation of growth|
|mitotic cell cycle phase transition|
|cell cycle phase transition|
|positive regulation of cell cycle process|
|positive regulation of cell cycle|
|regulation of cell growth|
|mitotic cell cycle process|
|regulation of growth|
|mitotic cell cycle|
|regulation of cell cycle process|
|cell cycle process|
|identical protein binding|
|regulation of cell cycle|
|positive regulation of transcription by RNA polymerase II|
|cell cycle|
|DNA binding|
|positive regulation of transcription, DNA-templated|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|positive regulation of signal transduction|
|positive regulation of RNA metabolic process|
|positive regulation of cell communication|
|positive regulation of signaling|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp77|Prochlorperazine 5.2μM R02 exp77]]|1.7|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 1/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|1/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 17881
* **Expression level (log2 read counts)**: 5.51
{{:chemogenomics:nalm6 dist.png?nolink |}}